North America Embolotherapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Embolotherapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Embolotherapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Embolotherapy Market Regional Analysis

6.2 North America Embolotherapy Market Revenue 2020-2028 (US$ Million)

6.3 North America Embolotherapy Market Forecast Analysis

7. North America Embolotherapy Market Analysis – by Product

7.1 Embolic Agent

7.1.1 Overview
7.1.2 Embolic Agent: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Support Device

7.2.1 Overview
7.2.2 Support Device: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Embolotherapy Market Analysis – by Disease Indication

8.1 Cancer

8.1.1 Overview
8.1.2 Cancer: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Peripheral Vascular Disease

8.2.1 Overview
8.2.2 Peripheral Vascular Disease: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Neurological Disease

8.3.1 Overview
8.3.2 Neurological Disease: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Urological and Nephrological Disorder

8.4.1 Overview
8.4.2 Urological and Nephrological Disorder: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Gastrointestinal Disorder

8.5.1 Overview
8.5.2 Gastrointestinal Disorder: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Embolotherapy Market Analysis – by Procedure

9.1 Transcatheter Arterial Embolization

9.1.1 Overview
9.1.2 Transcatheter Arterial Embolization: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

9.2.1 Overview
9.2.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Transarterial Chemoembolization

9.3.1 Overview
9.3.2 Transarterial Chemoembolization: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Embolotherapy Market Analysis – by End User

10.1 Hospital & Clinic

10.1.1 Overview
10.1.2 Hospital & Clinic: North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Ambulatory Surgery Center

10.2.1 Overview
10.2.2 Ambulatory Surgery Center : North America Embolotherapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. North America Embolotherapy Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Embolotherapy Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 North America Embolotherapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 US: North America Embolotherapy Market Breakdown, by Product
11.2.1.1.2 US: North America Embolotherapy Market Breakdown, by Disease Indication
11.2.1.1.3 US: North America Embolotherapy Market Breakdown, by Procedure
11.2.1.1.4 US: North America Embolotherapy Market Breakdown, by End User

11.2.1.2 Canada: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Canada: North America Embolotherapy Market Breakdown, by Product
11.2.1.2.2 Canada: North America Embolotherapy Market Breakdown, by Disease Indication
11.2.1.2.3 Canada: North America Embolotherapy Market Breakdown, by Procedure
11.2.1.2.4 Canada: North America Embolotherapy Market Breakdown, by End User

11.2.1.3 Mexico : North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Mexico : North America Embolotherapy Market Breakdown, by Product
11.2.1.3.2 Mexico : North America Embolotherapy Market Breakdown, by Disease Indication
11.2.1.3.3 Mexico : North America Embolotherapy Market Breakdown, by Procedure
11.2.1.3.4 Mexico : North America Embolotherapy Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Boston Scientific Corporation

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Cook Medical LLC

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Johnson & Johnson

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Medtronic

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Acandis GmbH

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Balt USA LLC

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Stryker Corporation

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Guerbet LLC

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Terumo Corporation

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Embolotherapy Market